68
Zhejiang Orient Gene Biotech Co., Ltd
688298.SS · SHH
¥18.06 -2.75% (-¥0.51)
1M -8.28%
Market Cap ¥3.73B
P/E Ratio -
Div. Yield -
ROE 10.38%
Piotroski F-Score Moderate
4/9Valuation
74 /100
Cheap P/B 0.65x
P/S 3.66x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 9.79%
Rev. growth 52.37%
FCF growth N/A
Profitability
20 /100
Weak Net margin 61.05%
Op. margin 56.54%
FCF margin 39.24%
Quality
2 /100
Poor ROE 10.38%
ROA 9.03%
Asset turnover 0.15x
Debt
69 /100
Low Current ratio 3.38x
Int. coverage -64.36x
Debt/Equity 0.06x
Stability
34 /100
Moderate Rev. volatility 57.17%
EPS volatility 57.38%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 688298.SS
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Xiao Liang Fang
Employees
2,283
Headquarters
Huzhou